Literature DB >> 16763573

First-in-class cancer therapeutic to stimulate natural killer cells.

Cormac Sheridan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16763573     DOI： 10.1038/nbt0606-597

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  2 in total

Review 1.  Cancer and innate immune system interactions: translational potentials for cancer immunotherapy.

Authors:  Yanan Liu; Gang Zeng
Journal:  J Immunother       Date:  2012-05       Impact factor: 4.456

2.  Poly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DC.

Authors:  Eva Lion; Sébastien Anguille; Zwi N Berneman; Evelien L J M Smits; Viggo F I Van Tendeloo
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.